This announcement is a separate document:
前沿生物：北京国枫（南京） 律师事务所关于前沿生物药业（南京）股份有限公司2024 年第三次临时股东大会的法律意见书
Frontier Biology: Legal Opinion of Beijing Guofeng (Nanjing) Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Frontier Biopharmaceuticals (Nanjing) Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated